#begin document (nw/wsj/09/wsj_0992); part 000
nw/wsj/09/wsj_0992   0    0       Regarding    VBG  (TOP(S(PP*    -    -   -   -               *    (ARGM-ADV*   -
nw/wsj/09/wsj_0992   0    1            your   PRP$     (NP(NP*    -    -   -   -               *             *   -
nw/wsj/09/wsj_0992   0    2            Oct.    NNP       (NML*    -    -   -   -          (DATE*             *   -
nw/wsj/09/wsj_0992   0    3              4      CD           *)   -    -   -   -               *)            *   -
nw/wsj/09/wsj_0992   0    4            page     NN       (NML*    -    -   -   -      (CARDINAL*             *   -
nw/wsj/09/wsj_0992   0    5              -    HYPH           *    -    -   -   -               *             *   -
nw/wsj/09/wsj_0992   0    6             one     CD           *)   -    -   -   -               *)            *   -
nw/wsj/09/wsj_0992   0    7         article     NN           *)   -    -   -   -               *             *   -
nw/wsj/09/wsj_0992   0    8              ``     ``           *    -    -   -   -               *             *   -
nw/wsj/09/wsj_0992   0    9             Bad    NNP        (NP*    -    -   -   -   (WORK_OF_ART*             *   -
nw/wsj/09/wsj_0992   0   10           Blood    NNP           *)   -    -   -   -               *)            *   -
nw/wsj/09/wsj_0992   0   11              ''     ''           *    -    -   -   -               *             *   -
nw/wsj/09/wsj_0992   0   12              on     IN        (PP*    -    -   -   -               *             *   -
nw/wsj/09/wsj_0992   0   13             the     DT        (NP*    -    -   -   -               *             *   -
nw/wsj/09/wsj_0992   0   14         generic     JJ       (NML*    -    -   -   -               *             *   -
nw/wsj/09/wsj_0992   0   15              -    HYPH           *    -    -   -   -               *             *   -
nw/wsj/09/wsj_0992   0   16            drug     NN           *)   -    -   -   -               *             *   -
nw/wsj/09/wsj_0992   0   17          battle     NN        *))))   -    -   -   -               *             *)  -
nw/wsj/09/wsj_0992   0   18               :      :           *    -    -   -   -               *             *   -
nw/wsj/09/wsj_0992   0   19             The     DT        (NP*    -    -   -   -           (ORG*        (ARG1*   -
nw/wsj/09/wsj_0992   0   20        Epilepsy    NNP           *    -    -   -   -               *             *   -
nw/wsj/09/wsj_0992   0   21       Institute    NNP           *)   -    -   -   -               *)            *)  -
nw/wsj/09/wsj_0992   0   22              is    VBZ        (VP*    be  01   -   -               *           (V*)  -
nw/wsj/09/wsj_0992   0   23             not     RB           *    -    -   -   -               *    (ARGM-NEG*)  -
nw/wsj/09/wsj_0992   0   24            just     RB        (NP*    -    -   -   -               *        (ARG2*   -
nw/wsj/09/wsj_0992   0   25               a     DT           *    -    -   -   -               *             *   -
nw/wsj/09/wsj_0992   0   26         patient     NN       (NML*    -    -   -   -               *             *   -
nw/wsj/09/wsj_0992   0   27              -    HYPH           *    -    -   -   -               *             *   -
nw/wsj/09/wsj_0992   0   28        advocacy     NN           *)   -    -   -   -               *             *   -
nw/wsj/09/wsj_0992   0   29    organization     NN          *))   -    -   -   -               *             *)  -
nw/wsj/09/wsj_0992   0   30               .      .          *))   -    -   -   -               *             *   -

nw/wsj/09/wsj_0992   0    0               It    PRP   (TOP(S(NP*)        -    -   -   -   *        (ARG1*)       *   -
nw/wsj/09/wsj_0992   0    1               is    VBZ         (VP*         be  01   -   -   *           (V*)       *   -
nw/wsj/09/wsj_0992   0    2        primarily     RB       (ADVP*)        -    -   -   -   *    (ARGM-ADV*)       *   -
nw/wsj/09/wsj_0992   0    3                a     DT      (NP(NP*         -    -   -   -   *        (ARG2*   (ARG0*   -
nw/wsj/09/wsj_0992   0    4        certified     JJ            *         -    -   -   -   *             *        *   -
nw/wsj/09/wsj_0992   0    5       outpatient     NN        (NML*         -    -   -   -   *             *        *   -
nw/wsj/09/wsj_0992   0    6        treatment     NN            *)        -    -   -   -   *             *        *   -
nw/wsj/09/wsj_0992   0    7         facility     NN            *)        -    -   -   -   *             *        *)  -
nw/wsj/09/wsj_0992   0    8        providing    VBG         (VP*    provide  01   -   -   *             *      (V*)  -
nw/wsj/09/wsj_0992   0    9    comprehensive     JJ         (NP*         -    -   -   -   *             *   (ARG1*   -
nw/wsj/09/wsj_0992   0   10         services    NNS            *)        -    -   -   -   *             *        *)  -
nw/wsj/09/wsj_0992   0   11               to     IN         (PP*         -    -   -   -   *             *   (ARG2*   -
nw/wsj/09/wsj_0992   0   12           people    NNS   (NP(NP(NP*)        -    -   -   -   *             *        *   -
nw/wsj/09/wsj_0992   0   13             with     IN         (PP*         -    -   -   -   *             *        *   -
nw/wsj/09/wsj_0992   0   14         epilepsy     NN       (NP*)))        -    -   -   -   *             *        *   -
nw/wsj/09/wsj_0992   0   15              and     CC            *         -    -   -   -   *             *        *   -
nw/wsj/09/wsj_0992   0   16            their   PRP$         (NP*         -    -   -   -   *             *        *   -
nw/wsj/09/wsj_0992   0   17         families    NNS       *))))))        -    -   -   -   *             *)       *)  -
nw/wsj/09/wsj_0992   0   18                .      .           *))        -    -   -   -   *             *        *   -

nw/wsj/09/wsj_0992   0    0           The    DT  (TOP(S(NP(NP*           -    -   -   -   *   (ARG1*         *         *   -
nw/wsj/09/wsj_0992   0    1     institute    NN              *           -    -   -   -   *        *         *         *   -
nw/wsj/09/wsj_0992   0    2            's   POS              *)          -    -   -   -   *        *         *         *   -
nw/wsj/09/wsj_0992   0    3      advocacy    NN              *           -    -   -   -   *        *         *         *   -
nw/wsj/09/wsj_0992   0    4       efforts   NNS              *)          -    -   -   -   *        *)        *         *   -
nw/wsj/09/wsj_0992   0    5           are   VBP           (VP*           -    -   -   -   *        *         *         *   -
nw/wsj/09/wsj_0992   0    6         based   VBN           (VP*         base  02   -   -   *      (V*)        *         *   -
nw/wsj/09/wsj_0992   0    7            on    IN           (PP*           -    -   -   -   *   (ARG2*         *         *   -
nw/wsj/09/wsj_0992   0    8           the    DT        (NP(NP*           -    -   -   -   *        *         *         *   -
nw/wsj/09/wsj_0992   0    9         needs   NNS              *)          -    -   -   -   *        *         *         *   -
nw/wsj/09/wsj_0992   0   10            of    IN           (PP*           -    -   -   -   *        *         *         *   -
nw/wsj/09/wsj_0992   0   11           the    DT        (NP(NP*           -    -   -   -   *        *    (ARG2*    (ARG1*   -
nw/wsj/09/wsj_0992   0   12    population    NN              *)          -    -   -   -   *        *         *)        *)  -
nw/wsj/09/wsj_0992   0   13            it   PRP    (SBAR(S(NP*)          -    -   -   -   *        *    (ARG0*)   (ARG0*)  -
nw/wsj/09/wsj_0992   0   14        serves   VBZ           (VP*        serve  01   -   -   *        *       (V*)        *   -
nw/wsj/09/wsj_0992   0   15           and    CC              *           -    -   -   -   *        *         *         *   -
nw/wsj/09/wsj_0992   0   16    represents   VBZ      *)))))))))   represent  01   -   -   *        *)        *       (V*)  -
nw/wsj/09/wsj_0992   0   17             .     .             *))          -    -   -   -   *        *         *         *   -

nw/wsj/09/wsj_0992   0    0                In     IN  (TOP(S(PP*           -    -   -   -        *   (ARGM-TMP*         *        *   -
nw/wsj/09/wsj_0992   0    1             1985      CD       (NP*))          -    -   -   -    (DATE)           *)        *        *   -
nw/wsj/09/wsj_0992   0    2                 ,      ,           *           -    -   -   -        *            *         *        *   -
nw/wsj/09/wsj_0992   0    3               the     DT        (NP*           -    -   -   -    (ORG*       (ARG0*         *        *   -
nw/wsj/09/wsj_0992   0    4           Medical    NNP           *           -    -   -   -        *            *         *        *   -
nw/wsj/09/wsj_0992   0    5           Tribune    NNP           *)          -    -   -   -        *)           *)        *        *   -
nw/wsj/09/wsj_0992   0    6          reported    VBD        (VP*       report  01   -   -        *          (V*)        *        *   -
nw/wsj/09/wsj_0992   0    7              that     IN      (SBAR*           -    -   -   -        *       (ARG1*         *        *   -
nw/wsj/09/wsj_0992   0    8                 a     DT   (S(NP(NP*           -    -   -   -        *            *         *   (ARG0*   -
nw/wsj/09/wsj_0992   0    9           growing    VBG           *         grow  01   -   -        *            *       (V*)       *   -
nw/wsj/09/wsj_0992   0   10            number     NN           *)          -    -   -   -        *            *    (ARG1*)       *   -
nw/wsj/09/wsj_0992   0   11                of     IN        (PP*           -    -   -   -        *            *         *        *   -
nw/wsj/09/wsj_0992   0   12           critics    NNS      (NP*)))          -    -   -   -        *            *         *        *)  -
nw/wsj/09/wsj_0992   0   13               are    VBP        (VP*           -    -   -   -        *            *         *        *   -
nw/wsj/09/wsj_0992   0   14       challenging    VBG        (VP*    challenge  01   1   -        *            *         *      (V*)  -
nw/wsj/09/wsj_0992   0   15               the     DT        (NP*           -    -   -   -        *            *         *   (ARG1*   -
nw/wsj/09/wsj_0992   0   16               FDA    NNP           *           -    -   -   -     (ORG)           *         *        *   -
nw/wsj/09/wsj_0992   0   17    bioequivalence     NN   (NML(NML*)          -    -   -   -        *            *         *        *   -
nw/wsj/09/wsj_0992   0   18                -    HYPH           *           -    -   -   -        *            *         *        *   -
nw/wsj/09/wsj_0992   0   19       therapeutic     JJ       (NML*           -    -   -   -        *            *         *        *   -
nw/wsj/09/wsj_0992   0   20                -    HYPH           *           -    -   -   -        *            *         *        *   -
nw/wsj/09/wsj_0992   0   21       equivalence     NN          *))          -    -   -   -        *            *         *        *   -
nw/wsj/09/wsj_0992   0   22          equation     NN      *))))))          -    -   -   -        *            *)        *        *)  -
nw/wsj/09/wsj_0992   0   23                 .      .          *))          -    -   -   -        *            *         *        *   -

nw/wsj/09/wsj_0992   0    0            ``    ``           (TOP(S*            -    -   -   -       *         *         *            *             *        *   -
nw/wsj/09/wsj_0992   0    1          They   PRP            (S(NP*)           -    -   -   -       *    (ARG0*)        *            *             *   (ARG1*   -
nw/wsj/09/wsj_0992   0    2       contend   VBP              (VP*       contend  01   1   -       *       (V*)        *            *             *        *   -
nw/wsj/09/wsj_0992   0    3            it   PRP       (SBAR(S(NP*)           -    -   -   -       *    (ARG1*    (ARG1*)           *             *        *   -
nw/wsj/09/wsj_0992   0    4            is   VBZ              (VP*            -    -   -   -       *         *         *            *             *        *   -
nw/wsj/09/wsj_0992   0    5         based   VBN              (VP*          base  02   -   -       *         *       (V*)           *             *        *   -
nw/wsj/09/wsj_0992   0    6            on    IN              (PP*            -    -   -   -       *         *    (ARG2*            *             *        *   -
nw/wsj/09/wsj_0992   0    7            an    DT           (NP(NP*            -    -   -   -       *         *         *            *        (ARG1*        *   -
nw/wsj/09/wsj_0992   0    8    assumption    NN                 *)   assumption  01   1   -       *         *         *          (V*)            *)       *   -
nw/wsj/09/wsj_0992   0    9          that   WDT       (SBAR(WHNP*)           -    -   -   -       *         *         *   (ARGM-ADJ*      (R-ARG1*)       *   -
nw/wsj/09/wsj_0992   0   10           has   VBZ            (S(VP*            -    -   -   -       *         *         *            *             *        *   -
nw/wsj/09/wsj_0992   0   11           not    RB                 *            -    -   -   -       *         *         *            *    (ARGM-NEG*)       *   -
nw/wsj/09/wsj_0992   0   12           yet    RB            (ADVP*)           -    -   -   -       *         *         *            *    (ARGM-TMP*)       *   -
nw/wsj/09/wsj_0992   0   13          been   VBN              (VP*            -    -   -   -       *         *         *            *             *        *   -
nw/wsj/09/wsj_0992   0   14        proven   VBN              (VP*         prove  01   -   -       *         *         *            *           (V*)       *   -
nw/wsj/09/wsj_0992   0   15            in    IN              (PP*            -    -   -   -       *         *         *            *    (ARGM-LOC*        *   -
nw/wsj/09/wsj_0992   0   16         valid    JJ              (NP*            -    -   -   -       *         *         *            *             *        *   -
nw/wsj/09/wsj_0992   0   17         tests   NNS   *)))))))))))))))           -    -   -   -       *         *)        *)           *)            *)       *)  -
nw/wsj/09/wsj_0992   0   18             ,     ,                 *            -    -   -   -       *         *         *            *             *        *   -
nw/wsj/09/wsj_0992   0   19            ''    ''                 *            -    -   -   -       *         *         *            *             *        *   -
nw/wsj/09/wsj_0992   0   20           the    DT              (NP*            -    -   -   -       *         *         *            *             *   (ARG0*   -
nw/wsj/09/wsj_0992   0   21       Tribune   NNP                 *)           -    -   -   -    (ORG)        *         *            *             *        *)  -
nw/wsj/09/wsj_0992   0   22          said   VBD              (VP*)          say  01   -   -       *         *         *            *             *      (V*)  -
nw/wsj/09/wsj_0992   0   23             .     .                *))           -    -   -   -       *         *         *            *             *        *   -

nw/wsj/09/wsj_0992   0    0              In     IN      (TOP(S(PP*        -    -   -   -        *   (ARGM-TMP*             *   -
nw/wsj/09/wsj_0992   0    1           1986      CD           (NP*))       -    -   -   -    (DATE)           *)            *   -
nw/wsj/09/wsj_0992   0    2               ,      ,               *        -    -   -   -        *            *             *   -
nw/wsj/09/wsj_0992   0    3            some     DT            (NP*        -    -   -   -        *       (ARG0*             *   -
nw/wsj/09/wsj_0992   0    4       institute     NN               *        -    -   -   -        *            *             *   -
nw/wsj/09/wsj_0992   0    5        patients    NNS               *)       -    -   -   -        *            *)            *   -
nw/wsj/09/wsj_0992   0    6            were    VBD            (VP*        -    -   -   -        *            *             *   -
nw/wsj/09/wsj_0992   0    7       reporting    VBG            (VP*    report  01   -   -        *          (V*)            *   -
nw/wsj/09/wsj_0992   0    8    breakthrough     NN            (NP*        -    -   -   -        *       (ARG1*             *   -
nw/wsj/09/wsj_0992   0    9        seizures    NNS               *)       -    -   -   -        *            *)            *   -
nw/wsj/09/wsj_0992   0   10            when    WRB   (SBAR(WHADVP*)       -    -   -   -        *   (ARGM-TMP*    (ARGM-TMP*)  -
nw/wsj/09/wsj_0992   0   11            they    PRP          (S(NP*)       -    -   -   -        *            *        (ARG1*)  -
nw/wsj/09/wsj_0992   0   12            were    VBD            (VP*        -    -   -   -        *            *             *   -
nw/wsj/09/wsj_0992   0   13        switched    VBN         (VP(VP*    switch  01   -   -        *            *           (V*)  -
nw/wsj/09/wsj_0992   0   14            from     IN            (PP*        -    -   -   -        *            *        (ARG3*   -
nw/wsj/09/wsj_0992   0   15               a     DT            (NP*        -    -   -   -        *            *             *   -
nw/wsj/09/wsj_0992   0   16        specific     JJ               *        -    -   -   -        *            *             *   -
nw/wsj/09/wsj_0992   0   17           brand     JJ           (NML*        -    -   -   -        *            *             *   -
nw/wsj/09/wsj_0992   0   18              -    HYPH               *        -    -   -   -        *            *             *   -
nw/wsj/09/wsj_0992   0   19            name     NN               *)       -    -   -   -        *            *             *   -
nw/wsj/09/wsj_0992   0   20      medication     NN              *))       -    -   -   -        *            *             *)  -
nw/wsj/09/wsj_0992   0   21              to     IN            (PP*        -    -   -   -        *            *        (ARG2*   -
nw/wsj/09/wsj_0992   0   22               a     DT            (NP*        -    -   -   -        *            *             *   -
nw/wsj/09/wsj_0992   0   23         generic     JJ               *        -    -   -   -        *            *             *   -
nw/wsj/09/wsj_0992   0   24             one     CD             *)))       -    -   -   -        *            *             *)  -
nw/wsj/09/wsj_0992   0   25              or     CC               *        -    -   -   -        *            *             *   -
nw/wsj/09/wsj_0992   0   26            from     IN         (VP(PP*        -    -   -   -        *            *             *   -
nw/wsj/09/wsj_0992   0   27             one     CD         (NP(NP*        -    -   -   -        *            *             *   -
nw/wsj/09/wsj_0992   0   28         generic     JJ               *        -    -   -   -        *            *             *   -
nw/wsj/09/wsj_0992   0   29    manufacturer     NN               *)       -    -   -   -        *            *             *   -
nw/wsj/09/wsj_0992   0   30              of     IN            (PP*        -    -   -   -        *            *             *   -
nw/wsj/09/wsj_0992   0   31               a     DT            (NP*        -    -   -   -        *            *             *   -
nw/wsj/09/wsj_0992   0   32        specific     JJ               *        -    -   -   -        *            *             *   -
nw/wsj/09/wsj_0992   0   33         product     NN            *))))       -    -   -   -        *            *             *   -
nw/wsj/09/wsj_0992   0   34              to     IN            (PP*        -    -   -   -        *            *             *   -
nw/wsj/09/wsj_0992   0   35         another     DT    (NP*)))))))))       -    -   -   -        *            *)            *   -
nw/wsj/09/wsj_0992   0   36               .      .              *))       -    -   -   -        *            *             *   -

nw/wsj/09/wsj_0992   0    0              In    IN  (TOP(S(PP*        -    -   -   -   *   (ARGM-DIS*            *   -
nw/wsj/09/wsj_0992   0    1        addition    NN       (NP*))       -    -   -   -   *            *)           *   -
nw/wsj/09/wsj_0992   0    2               ,     ,           *        -    -   -   -   *            *            *   -
nw/wsj/09/wsj_0992   0    3    neurologists   NNS        (NP*)       -    -   -   -   *       (ARG0*)      (ARG0*)  -
nw/wsj/09/wsj_0992   0    4            were   VBD        (VP*        -    -   -   -   *            *            *   -
nw/wsj/09/wsj_0992   0    5       beginning   VBG        (VP*     begin  01   -   -   *          (V*)           *   -
nw/wsj/09/wsj_0992   0    6              to    TO      (S(VP*        -    -   -   -   *       (ARG1*            *   -
nw/wsj/09/wsj_0992   0    7          report    VB        (VP*    report  01   -   -   *            *          (V*)  -
nw/wsj/09/wsj_0992   0    8           these    DT        (NP*        -    -   -   -   *            *       (ARG1*   -
nw/wsj/09/wsj_0992   0    9    observations   NNS           *)       -    -   -   -   *            *            *)  -
nw/wsj/09/wsj_0992   0   10              as    RB      (ADVP*        -    -   -   -   *            *   (ARGM-DIS*   -
nw/wsj/09/wsj_0992   0   11            well    RB      *))))))       -    -   -   -   *            *)           *)  -
nw/wsj/09/wsj_0992   0   12               .     .          *))       -    -   -   -   *            *            *   -

nw/wsj/09/wsj_0992   0   0         Call    VB  (TOP(S(VP*    call  01   -   -   *          (V*)  -
nw/wsj/09/wsj_0992   0   1           it   PRP        (NP*)     -    -   -   -   *       (ARG1*)  -
nw/wsj/09/wsj_0992   0   2    anecdotal    JJ   (S(ADJP*))     -    -   -   -   *       (ARG2*)  -
nw/wsj/09/wsj_0992   0   3           if    IN      (SBAR*      -    -   -   -   *   (ARGM-ADV*   -
nw/wsj/09/wsj_0992   0   4          you   PRP      (S(NP*)     -    -   -   -   *            *   -
nw/wsj/09/wsj_0992   0   5         will    MD     (VP*))))     -    -   -   -   *            *)  -
nw/wsj/09/wsj_0992   0   6            .     .          *))     -    -   -   -   *            *   -

nw/wsj/09/wsj_0992   0    0             But    CC       (TOP(S*        -    -   -   -   *    (ARGM-DIS*)            *        *   -
nw/wsj/09/wsj_0992   0    1              no    DT          (NP*        -    -   -   -   *        (ARG0*             *   (ARG0*   -
nw/wsj/09/wsj_0992   0    2         ethical    JJ             *        -    -   -   -   *             *             *        *   -
nw/wsj/09/wsj_0992   0    3       physician    NN             *)       -    -   -   -   *             *)            *        *)  -
nw/wsj/09/wsj_0992   0    4           would    MD          (VP*        -    -   -   -   *    (ARGM-MOD*)            *        *   -
nw/wsj/09/wsj_0992   0    5          switch    VB          (VP*    switch  01   1   -   *           (V*)            *        *   -
nw/wsj/09/wsj_0992   0    6        patients   NNS       (NP(NP*)       -    -   -   -   *        (ARG1*        (ARG0*)       *   -
nw/wsj/09/wsj_0992   0    7             who    WP   (SBAR(WHNP*)       -    -   -   -   *             *      (R-ARG0*)       *   -
nw/wsj/09/wsj_0992   0    8            were   VBD        (S(VP*        -    -   -   -   *             *             *        *   -
nw/wsj/09/wsj_0992   0    9           doing   VBG          (VP*        do  02   -   -   *             *           (V*)       *   -
nw/wsj/09/wsj_0992   0   10            well    RB        (ADVP*)       -    -   -   -   *             *    (ARGM-MNR*)       *   -
nw/wsj/09/wsj_0992   0   11              on    IN          (PP*        -    -   -   -   *             *        (ARG3*        *   -
nw/wsj/09/wsj_0992   0   12               a    DT       (NP(NP*        -    -   -   -   *             *             *        *   -
nw/wsj/09/wsj_0992   0   13        specific    JJ             *        -    -   -   -   *             *             *        *   -
nw/wsj/09/wsj_0992   0   14      medication    NN             *)       -    -   -   -   *             *             *        *   -
nw/wsj/09/wsj_0992   0   15            from    IN          (PP*        -    -   -   -   *             *             *        *   -
nw/wsj/09/wsj_0992   0   16               a    DT          (NP*        -    -   -   -   *             *             *        *   -
nw/wsj/09/wsj_0992   0   17        specific    JJ             *        -    -   -   -   *             *             *        *   -
nw/wsj/09/wsj_0992   0   18    manufacturer    NN     *)))))))))       -    -   -   -   *             *)            *)       *   -
nw/wsj/09/wsj_0992   0   19              to    TO        (S(VP*        -    -   -   -   *    (ARGM-PRP*             *        *   -
nw/wsj/09/wsj_0992   0   20           prove    VB          (VP*     prove  01   -   -   *             *             *      (V*)  -
nw/wsj/09/wsj_0992   0   21               a    DT          (NP*        -    -   -   -   *             *             *   (ARG1*   -
nw/wsj/09/wsj_0992   0   22           point    NN        *))))))       -    -   -   -   *             *)            *        *)  -
nw/wsj/09/wsj_0992   0   23               .     .            *))       -    -   -   -   *             *             *        *   -

nw/wsj/09/wsj_0992   0    0                We    PRP   (TOP(S(NP*)       -    -   -   -   *        (ARG0*)  -
nw/wsj/09/wsj_0992   0    1                do    VBP         (VP*        -    -   -   -   *             *   -
nw/wsj/09/wsj_0992   0    2               not     RB            *        -    -   -   -   *    (ARGM-NEG*)  -
nw/wsj/09/wsj_0992   0    3            depend     VB         (VP*    depend  01   -   -   *           (V*)  -
nw/wsj/09/wsj_0992   0    4                on     IN         (PP*        -    -   -   -   *        (ARG1*   -
nw/wsj/09/wsj_0992   0    5    pharmaceutical     JJ         (NP*        -    -   -   -   *             *   -
nw/wsj/09/wsj_0992   0    6         companies    NNS           *))       -    -   -   -   *             *)  -
nw/wsj/09/wsj_0992   0    7               for     IN         (PP*        -    -   -   -   *    (ARGM-PNC*   -
nw/wsj/09/wsj_0992   0    8               our   PRP$         (NP*        -    -   -   -   *             *   -
nw/wsj/09/wsj_0992   0    9           support     NN         *))))       -    -   -   -   *             *)  -
nw/wsj/09/wsj_0992   0   10                 .      .           *))       -    -   -   -   *             *   -

nw/wsj/09/wsj_0992   0    0              The    DT  (TOP(S(NP*         -    -   -   -   *   (ARG0*   (ARG0*       (ARG0*   -
nw/wsj/09/wsj_0992   0    1        institute    NN           *)        -    -   -   -   *        *)       *)           *)  -
nw/wsj/09/wsj_0992   0    2              has   VBZ     (VP(VP*       have  03   -   -   *      (V*)       *            *   -
nw/wsj/09/wsj_0992   0    3     governmental    JJ     (NP(NP*         -    -   -   -   *   (ARG1*        *            *   -
nw/wsj/09/wsj_0992   0    4          service    NN           *         -    -   -   -   *        *        *            *   -
nw/wsj/09/wsj_0992   0    5        contracts   NNS           *)        -    -   -   -   *        *        *            *   -
nw/wsj/09/wsj_0992   0    6              for    IN        (PP*         -    -   -   -   *        *        *            *   -
nw/wsj/09/wsj_0992   0    7              the    DT     (NP(NP*         -    -   -   -   *        *        *            *   -
nw/wsj/09/wsj_0992   0    8        provision    NN           *)        -    -   -   -   *        *        *            *   -
nw/wsj/09/wsj_0992   0    9               of    IN        (PP*         -    -   -   -   *        *        *            *   -
nw/wsj/09/wsj_0992   0   10           direct    JJ        (NP*         -    -   -   -   *        *        *            *   -
nw/wsj/09/wsj_0992   0   11          patient    NN           *         -    -   -   -   *        *        *            *   -
nw/wsj/09/wsj_0992   0   12         services   NNS      *))))))        -    -   -   -   *        *)       *            *   -
nw/wsj/09/wsj_0992   0   13                ;     :           *         -    -   -   -   *        *        *            *   -
nw/wsj/09/wsj_0992   0   14         collects   VBZ        (VP*    collect  01   -   -   *        *      (V*)           *   -
nw/wsj/09/wsj_0992   0   15          patient    JJ        (NP*         -    -   -   -   *        *   (ARG1*            *   -
nw/wsj/09/wsj_0992   0   16             fees   NNS          *))        -    -   -   -   *        *        *)           *   -
nw/wsj/09/wsj_0992   0   17                ;     :           *         -    -   -   -   *        *        *            *   -
nw/wsj/09/wsj_0992   0   18         receives   VBZ        (VP*    receive  01   -   -   *        *        *          (V*)  -
nw/wsj/09/wsj_0992   0   19            money    NN        (NP*)        -    -   -   -   *        *        *       (ARG1*)  -
nw/wsj/09/wsj_0992   0   20          through    IN        (PP*         -    -   -   -   *        *        *   (ARGM-MNR*   -
nw/wsj/09/wsj_0992   0   21    contributions   NNS     (NP(NP*)        -    -   -   -   *        *        *            *   -
nw/wsj/09/wsj_0992   0   22             from    IN        (PP*         -    -   -   -   *        *        *            *   -
nw/wsj/09/wsj_0992   0   23      individuals   NNS        (NP*         -    -   -   -   *        *        *            *   -
nw/wsj/09/wsj_0992   0   24                ,     ,           *         -    -   -   -   *        *        *            *   -
nw/wsj/09/wsj_0992   0   25      foundations   NNS           *         -    -   -   -   *        *        *            *   -
nw/wsj/09/wsj_0992   0   26              and    CC           *         -    -   -   -   *        *        *            *   -
nw/wsj/09/wsj_0992   0   27         bequests   NNS      *))))))        -    -   -   -   *        *        *            *)  -
nw/wsj/09/wsj_0992   0   28                .     .          *))        -    -   -   -   *        *        *            *   -

nw/wsj/09/wsj_0992   0    0               The    DT  (TOP(S(S(NP(NP*         -    -   -   -   *   (ARG1*   (ARG1*   (ARG2*             *   -
nw/wsj/09/wsj_0992   0    1             funds   NNS                *)        -    -   -   -   *        *)       *        *             *   -
nw/wsj/09/wsj_0992   0    2          received   VBN             (VP*    receive  01   -   -   *      (V*)       *        *             *   -
nw/wsj/09/wsj_0992   0    3              from    IN             (PP*         -    -   -   -   *   (ARG2*        *        *             *   -
nw/wsj/09/wsj_0992   0    4    pharmaceutical    JJ             (NP*         -    -   -   -   *        *        *        *             *   -
nw/wsj/09/wsj_0992   0    5             firms   NNS             *))))        -    -   -   -   *        *)       *)       *)            *   -
nw/wsj/09/wsj_0992   0    6               are   VBP             (VP*         -    -   -   -   *        *        *        *             *   -
nw/wsj/09/wsj_0992   0    7              used   VBN             (VP*        use  01   -   -   *        *      (V*)       *             *   -
nw/wsj/09/wsj_0992   0    8                to    TO           (S(VP*         -    -   -   -   *        *   (ARG2*        *             *   -
nw/wsj/09/wsj_0992   0    9            offset    VB             (VP*     offset  01   1   -   *        *        *      (V*)            *   -
nw/wsj/09/wsj_0992   0   10         physician    NN             (NP*         -    -   -   -   *        *        *   (ARG1*             *   -
nw/wsj/09/wsj_0992   0   11        symposiums   NNS          *)))))))        -    -   -   -   *        *        *)       *)            *   -
nw/wsj/09/wsj_0992   0   12                 ,     ,                *         -    -   -   -   *        *        *        *             *   -
nw/wsj/09/wsj_0992   0   13               and    CC                *         -    -   -   -   *        *        *        *             *   -
nw/wsj/09/wsj_0992   0   14             these    DT           (S(NP*         -    -   -   -   *        *        *        *        (ARG0*   -
nw/wsj/09/wsj_0992   0   15        symposiums   NNS                *)        -    -   -   -   *        *        *        *             *)  -
nw/wsj/09/wsj_0992   0   16                do   VBP             (VP*         -    -   -   -   *        *        *        *             *   -
nw/wsj/09/wsj_0992   0   17               not    RB                *         -    -   -   -   *        *        *        *    (ARGM-NEG*)  -
nw/wsj/09/wsj_0992   0   18            stress    VB             (VP*     stress  01   -   -   *        *        *        *           (V*)  -
nw/wsj/09/wsj_0992   0   19               any    DT             (NP*         -    -   -   -   *        *        *        *        (ARG1*   -
nw/wsj/09/wsj_0992   0   20        particular    JJ                *         -    -   -   -   *        *        *        *             *   -
nw/wsj/09/wsj_0992   0   21        medication    NN                *         -    -   -   -   *        *        *        *             *   -
nw/wsj/09/wsj_0992   0   22                or    CC                *         -    -   -   -   *        *        *        *             *   -
nw/wsj/09/wsj_0992   0   23      manufacturer    NN             *))))        -    -   -   -   *        *        *        *             *)  -
nw/wsj/09/wsj_0992   0   24                 .     .               *))        -    -   -   -   *        *        *        *             *   -

nw/wsj/09/wsj_0992   0    0             The    DT  (TOP(S(NP(NP(NP*       -    -   -   -    (ORG*   (ARG1*             *             *   -
nw/wsj/09/wsj_0992   0    1        Epilepsy   NNP                 *       -    -   -   -        *        *             *             *   -
nw/wsj/09/wsj_0992   0    2       Institute   NNP                 *       -    -   -   -        *        *             *             *   -
nw/wsj/09/wsj_0992   0    3              's   POS                 *)      -    -   -   -        *)       *             *             *   -
nw/wsj/09/wsj_0992   0    4       reporting    NN                 *)      -    -   -   -        *        *             *             *   -
nw/wsj/09/wsj_0992   0    5              of    IN              (PP*       -    -   -   -        *        *             *             *   -
nw/wsj/09/wsj_0992   0    6    breakthrough    NN              (NP*       -    -   -   -        *        *             *             *   -
nw/wsj/09/wsj_0992   0    7        seizures   NNS               *)))      -    -   -   -        *        *)            *             *   -
nw/wsj/09/wsj_0992   0    8         stemmed   VBD              (VP*     stem  01   1   -        *      (V*)            *             *   -
nw/wsj/09/wsj_0992   0    9            from    IN              (PP*       -    -   -   -        *   (ARG2*             *             *   -
nw/wsj/09/wsj_0992   0   10        concerns   NNS           (NP(NP*)      -    -   -   -        *        *             *             *   -
nw/wsj/09/wsj_0992   0   11           about    IN              (PP*       -    -   -   -        *        *             *             *   -
nw/wsj/09/wsj_0992   0   12             the    DT           (NP(NP*       -    -   -   -        *        *        (ARG1*        (ARG1*   -
nw/wsj/09/wsj_0992   0   13          people   NNS                 *)      -    -   -   -        *        *             *)            *)  -
nw/wsj/09/wsj_0992   0   14              we   PRP       (SBAR(S(NP*)      -    -   -   -        *        *        (ARG0*)       (ARG0*)  -
nw/wsj/09/wsj_0992   0   15           treat   VBP           (VP(VP*)   treat  03   -   -        *        *           (V*)            *   -
nw/wsj/09/wsj_0992   0   16             and    CC                 *       -    -   -   -        *        *             *             *   -
nw/wsj/09/wsj_0992   0   17            care   VBP              (VP*     care  01   -   -        *        *             *           (V*)  -
nw/wsj/09/wsj_0992   0   18           about    IN             (PP*))      -    -   -   -   (DATE*        *             *             *   -
nw/wsj/09/wsj_0992   0   19           daily    RB    (ADVP*)))))))))      -    -   -   -        *)       *)   (ARGM-TMP*)   (ARGM-TMP*)  -
nw/wsj/09/wsj_0992   0   20               .     .                *))      -    -   -   -        *        *             *             *   -

nw/wsj/09/wsj_0992   0    0          This    DT   (TOP(S(NP*)         -    -   -   -   *        (ARG1*)  -
nw/wsj/09/wsj_0992   0    1       perhaps    RB       (ADVP*)         -    -   -   -   *    (ARGM-ADV*)  -
nw/wsj/09/wsj_0992   0    2           was   VBD         (VP*          -    -   -   -   *             *   -
nw/wsj/09/wsj_0992   0    3     perceived   VBN         (VP*    perceive  01   3   -   *           (V*)  -
nw/wsj/09/wsj_0992   0    4            as    IN         (PP*          -    -   -   -   *        (ARG2*   -
nw/wsj/09/wsj_0992   0    5             a    DT     (UCP(NP*          -    -   -   -   *             *   -
nw/wsj/09/wsj_0992   0    6            ``    ``            *          -    -   -   -   *             *   -
nw/wsj/09/wsj_0992   0    7          bold    JJ            *          -    -   -   -   *             *   -
nw/wsj/09/wsj_0992   0    8            ''    ''            *          -    -   -   -   *             *   -
nw/wsj/09/wsj_0992   0    9        stance    NN            *)         -    -   -   -   *             *   -
nw/wsj/09/wsj_0992   0   10             ,     ,            *          -    -   -   -   *             *   -
nw/wsj/09/wsj_0992   0   11           and    CC            *          -    -   -   -   *             *   -
nw/wsj/09/wsj_0992   0   12          thus    RB            *          -    -   -   -   *             *   -
nw/wsj/09/wsj_0992   0   13    suspicious    JJ   (ADJP*)))))         -    -   -   -   *             *)  -
nw/wsj/09/wsj_0992   0   14             .     .           *))         -    -   -   -   *             *   -

nw/wsj/09/wsj_0992   0    0             But    CC      (TOP(S*            -    -   -   -   *    (ARGM-DIS*)            *        *   -
nw/wsj/09/wsj_0992   0    1             let    VB         (VP*           let  01   -   -   *           (V*)            *        *   -
nw/wsj/09/wsj_0992   0    2              us   PRP       (S(NP*)           -    -   -   -   *        (ARG1*        (ARG1*)       *   -
nw/wsj/09/wsj_0992   0    3             not    RB            *            -    -   -   -   *             *    (ARGM-NEG*)       *   -
nw/wsj/09/wsj_0992   0    4         confuse    VB         (VP*       confuse  01   1   -   *             *           (V*)       *   -
nw/wsj/09/wsj_0992   0    5         profits   NNS   (NP(NP(NP*)           -    -   -   -   *             *        (ARG2*   (ARG0*   -
nw/wsj/09/wsj_0992   0    6              of    IN         (PP*            -    -   -   -   *             *             *        *   -
nw/wsj/09/wsj_0992   0    7             big    JJ         (NP*            -    -   -   -   *             *             *        *   -
nw/wsj/09/wsj_0992   0    8        business    NN          *)))           -    -   -   -   *             *             *        *)  -
nw/wsj/09/wsj_0992   0    9    masquerading   VBG         (VP*    masquerade  01   -   -   *             *             *      (V*)  -
nw/wsj/09/wsj_0992   0   10              as    IN         (PP*            -    -   -   -   *             *             *   (ARG1*   -
nw/wsj/09/wsj_0992   0   11        concerns   NNS      (NP(NP*)           -    -   -   -   *             *             *        *   -
nw/wsj/09/wsj_0992   0   12             for    IN      (PP(PP*            -    -   -   -   *             *             *        *   -
nw/wsj/09/wsj_0992   0   13          people   NNS      (NP(NP*            -    -   -   -   *             *             *        *   -
nw/wsj/09/wsj_0992   0   14              's   POS            *)           -    -   -   -   *             *             *        *   -
nw/wsj/09/wsj_0992   0   15          health    NN            *            -    -   -   -   *             *             *        *   -
nw/wsj/09/wsj_0992   0   16            care    NN           *))           -    -   -   -   *             *             *        *   -
nw/wsj/09/wsj_0992   0   17              or    CC            *            -    -   -   -   *             *             *        *   -
nw/wsj/09/wsj_0992   0   18             for    IN         (PP*            -    -   -   -   *             *             *        *   -
nw/wsj/09/wsj_0992   0   19             the    DT         (NP*            -    -   -   -   *             *             *        *   -
nw/wsj/09/wsj_0992   0   20            cost    NN   *))))))))))           -    -   -   -   *             *)            *)       *)  -
nw/wsj/09/wsj_0992   0   21               .     .           *))           -    -   -   -   *             *             *        *   -

nw/wsj/09/wsj_0992   0   0       For    IN  (TOP(SBARQ(WHPP*    -    -   -   -   *   (ARG2*   -
nw/wsj/09/wsj_0992   0   1      whom    WP           (WHNP*))   -    -   -   -   *        *)  -
nw/wsj/09/wsj_0992   0   2        is   VBZ              (SQ*    be  01   -   -   *      (V*)  -
nw/wsj/09/wsj_0992   0   3       the    DT              (NP*    -    -   -   -   *   (ARG1*   -
nw/wsj/09/wsj_0992   0   4    saving    NN                *))   -    -   -   -   *        *)  -
nw/wsj/09/wsj_0992   0   5         ?     .                *))   -    -   -   -   *        *   -

nw/wsj/09/wsj_0992   0    0         Surely     RB   (TOP(FRAG(ADVP*)         -    -   -   -        *             *           *   -
nw/wsj/09/wsj_0992   0    1            not     RB                 *          -    -   -   -        *             *           *   -
nw/wsj/09/wsj_0992   0    2             to     IN              (PP*          -    -   -   -        *             *           *   -
nw/wsj/09/wsj_0992   0    3         people    NNS        (NP(NP(NP*)         -    -   -   -        *        (ARG0*      (ARG0*   -
nw/wsj/09/wsj_0992   0    4           with     IN              (PP*          -    -   -   -        *             *           *   -
nw/wsj/09/wsj_0992   0    5       epilepsy     NN            (NP*)))         -    -   -   -        *             *)          *)  -
nw/wsj/09/wsj_0992   0    6            who     WP       (SBAR(WHNP*)         -    -   -   -        *      (R-ARG0*)   (R-ARG0*)  -
nw/wsj/09/wsj_0992   0    7         depend    VBP            (S(VP*      depend  01   -   -        *           (V*)          *   -
nw/wsj/09/wsj_0992   0    8             on     IN              (PP*          -    -   -   -        *        (ARG1*           *   -
nw/wsj/09/wsj_0992   0    9            the     DT           (NP(NP*          -    -   -   -        *             *           *   -
nw/wsj/09/wsj_0992   0   10           same     JJ                 *          -    -   -   -        *             *           *   -
nw/wsj/09/wsj_0992   0   11         levels    NNS                 *)         -    -   -   -        *             *           *   -
nw/wsj/09/wsj_0992   0   12             of     IN              (PP*          -    -   -   -        *             *           *   -
nw/wsj/09/wsj_0992   0   13     medication     NN             (NP*))         -    -   -   -        *             *           *   -
nw/wsj/09/wsj_0992   0   14             in     IN              (PP*          -    -   -   -        *             *           *   -
nw/wsj/09/wsj_0992   0   15          their   PRP$              (NP*          -    -   -   -        *             *           *   -
nw/wsj/09/wsj_0992   0   16    bloodstream     NN              *))))         -    -   -   -        *             *)          *   -
nw/wsj/09/wsj_0992   0   17          daily     RB            (ADVP*)         -    -   -   -    (DATE)   (ARGM-TMP*)          *   -
nw/wsj/09/wsj_0992   0   18             to     TO            (S(VP*          -    -   -   -        *    (ARGM-PRP*           *   -
nw/wsj/09/wsj_0992   0   19       maintain     VB              (VP*    maintain  01   -   -        *             *         (V*)  -
nw/wsj/09/wsj_0992   0   20        seizure     NN              (NP*          -    -   -   -        *             *      (ARG1*   -
nw/wsj/09/wsj_0992   0   21        control     NN         *)))))))))         -    -   -   -        *             *)          *)  -
nw/wsj/09/wsj_0992   0   22              .      .                *))         -    -   -   -        *             *           *   -

nw/wsj/09/wsj_0992   0   0     Reina   NNP  (TOP(NP*   -   -   -   -   (PERSON*   -
nw/wsj/09/wsj_0992   0   1    Berner   NNP        *))  -   -   -   -          *)  -

nw/wsj/09/wsj_0992   0   0    Executive   NNP  (TOP(NP*   -   -   -   -   *   -
nw/wsj/09/wsj_0992   0   1     Director   NNP        *))  -   -   -   -   *   -

nw/wsj/09/wsj_0992   0   0    Arnold   NNP  (TOP(NP*   -   -   -   -   (PERSON*   -
nw/wsj/09/wsj_0992   0   1        M.   NNP         *   -   -   -   -          *   -
nw/wsj/09/wsj_0992   0   2      Katz   NNP        *))  -   -   -   -          *)  -

#end document
